These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32293335)

  • 1. Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer.
    Trilla-Fuertes L; Gámez-Pozo A; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; López-Vacas R; Arevalillo JM; Díaz-Almirón M; Navarro H; Maín P; Espinosa E; Zamora P; Fresno Vara JÁ
    BMC Cancer; 2020 Apr; 20(1):307. PubMed ID: 32293335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate enrichment as new diagnostic opportunity in breast cancer.
    Budczies J; Pfitzner BM; Györffy B; Winzer KJ; Radke C; Dietel M; Fiehn O; Denkert C
    Int J Cancer; 2015 Apr; 136(7):1619-28. PubMed ID: 25155347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
    Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
    Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Treatment or PRODH/POX-Knock out Similarly Induces Apoptosis by Reprograming of Amino Acid Metabolism, TCA, Urea Cycle and Pentose Phosphate Pathway in MCF-7 Breast Cancer Cells.
    Huynh TYL; Oscilowska I; Sáiz J; Nizioł M; Baszanowska W; Barbas C; Palka J
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    El Ansari R; McIntyre A; Craze ML; Ellis IO; Rakha EA; Green AR
    Histopathology; 2018 Jan; 72(2):183-190. PubMed ID: 28771772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.
    Zhang R; Zhuang X; Zong L; Liu S; Liu Z; Song F
    Anal Bioanal Chem; 2016 Aug; 408(21):5843-5854. PubMed ID: 27379392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells.
    Baumann J; Wong J; Sun Y; Conklin DS
    BMC Cancer; 2016 Jul; 16():551. PubMed ID: 27464732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
    Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
    Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer.
    Lord SR; Cheng WC; Liu D; Gaude E; Haider S; Metcalf T; Patel N; Teoh EJ; Gleeson F; Bradley K; Wigfield S; Zois C; McGowan DR; Ah-See ML; Thompson AM; Sharma A; Bidaut L; Pollak M; Roy PG; Karpe F; James T; English R; Adams RF; Campo L; Ayers L; Snell C; Roxanis I; Frezza C; Fenwick JD; Buffa FM; Harris AL
    Cell Metab; 2018 Nov; 28(5):679-688.e4. PubMed ID: 30244975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labeling Cancer Stem Cells with
    Kesh K; Banerjee S
    Methods Mol Biol; 2019; 1996():207-216. PubMed ID: 31127559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics.
    Bayet-Robert M; Lim S; Barthomeuf C; Morvan D
    Biochem Pharmacol; 2010 Oct; 80(8):1170-9. PubMed ID: 20637732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Footprints and Molecular Subtypes in Breast Cancer.
    Cappelletti V; Iorio E; Miodini P; Silvestri M; Dugo M; Daidone MG
    Dis Markers; 2017; 2017():7687851. PubMed ID: 29434411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
    Nam H; Chung BC; Kim Y; Lee K; Lee D
    Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics.
    Lane AN; Tan J; Wang Y; Yan J; Higashi RM; Fan TW
    Metab Eng; 2017 Sep; 43(Pt B):125-136. PubMed ID: 28163219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics.
    Dubuis S; Baenke F; Scherbichler N; Alexander LT; Schulze A; Zamboni N
    Metab Eng; 2017 Sep; 43(Pt B):173-186. PubMed ID: 28038952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
    Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
    Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic Response to XD14 Treatment in Human Breast Cancer Cell Line MCF-7.
    Pan D; Kather M; Willmann L; Schlimpert M; Bauer C; Lagies S; Schmidtkunz K; Eisenhardt SU; Jung M; Günther S; Kammerer B
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merging transcriptomics and metabolomics--advances in breast cancer profiling.
    Borgan E; Sitter B; Lingjærde OC; Johnsen H; Lundgren S; Bathen TF; Sørlie T; Børresen-Dale AL; Gribbestad IS
    BMC Cancer; 2010 Nov; 10():628. PubMed ID: 21080935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
    Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
    Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.